Journals

AJMCtv Interviews: ASH19 Edition
Evidence-Based Oncology > January 2020
Produced by Laura Joszt and Matthew Gavidia
Biosimilars at ASH 2019: Data on Truxima and Competitors for Eculizumab
Evidence-Based Oncology > January 2020
Kelly Davio
ASH 2019 Interview: Data Show Fixed-Dose Daunorubicin Plus Cytarabine Leads to Fewer Inpatient Days for Patients With sAML
Evidence-Based Oncology > January 2020
Mary Caffrey
ASH 2019: Patient-Reported Outcomes, From MOST to FDA Clincal Reviews
Evidence-Based Oncology > January 2020
Maggie L. Shaw
ASH 2019: Real-World Evidence and Cost of Care
Evidence-Based Oncology > January 2020
Maggie L. Shaw and Mary Caffrey
ASH 2019 Clinical Findings: CAPTIVATE, CANDOR, Blinatumomab, and More
Evidence-Based Oncology > January 2020
Mary Caffrey
CAR T-Cell Therapy and Beyond: UCART 19 and Anti-BCMA Therapy
Evidence-Based Oncology > January 2020
Mary Caffrey
CAR T-Cell Therapy and Beyond: Off-the-Shelf Therapies Among Innovations at ASH 2019
Evidence-Based Oncology > January 2020
Mary Caffrey
Exclusive Coverage of the San Antonio Breast Cancer Symposium
Supplements > Exclusive Coverage of the 2019 San Antonio Breast Cancer Symposium
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.